The study found that Thymosin α1 enhances the antigen-presenting capacity of dendritic cells and improves T lymphocyte responses to Human…
Evaluation of the effects of Thymosin β4 (Tβ4) on the intestinal mucus barrier in a mouse model of colitis suggest…
Conceptual and therapeutic approach to aging will significantly benefit from observing, extending and harnessing our knowledge regarding embryonic development and…
Israeli scientists have included Tα1 in the HIPEC (heated intra-peritoneal chemotherapy) method in the treatment of peritoneal metastases from colorectal…
The article prepared for publication in the “Journal of Biomedical Research and Therapeutics” describes for the first time the effect…
Thymosin α1 (Tα1) combined with multi-modal chemotherapy has a visible therapeutic effect on patients with pulmonary tuberculosis and diabetes by…
An article published in May 2022 in the journal Frontiers in Pharmacology describes the effect of calf thymus polypeptides on…
Thymosin β4 as a multifunctional bioactive molecule plays a key role in the protection of nerve tissue and in the…
Pharmfactor (belonging to the corporate group led by Biomedycyna Polska S.A.) has finalized the patent application submission process with the…
Biomedycyna Polska S.A., an active business entity with a mission of perpetual contribution to the availability of effective solutions used in treatment…